Benchmark sees sluggish end-user markets, cuts Harvard Bioscience shares target
On Friday, Benchmark lowered its price target on Harvard Bioscience Inc. (NASDAQ:) shares to $5.50...
On Friday, Benchmark lowered its price target on Harvard Bioscience Inc. (NASDAQ:) shares to $5.50...
By Kevin Buckland and Sruthi Shankar TOKYO (Reuters) -The dollar was close to a one-week...
On Friday, Baird raised the price target for Curtiss-Wright (NYSE:) shares to $312 from $300,...
On Friday, Needham raised its rating on shares of Doximity Inc (NYSE:) to Buy, citing...
On Friday, Baird raised the price target for CyberArk Software (NASDAQ:) shares to $315 from...
Diodes Incorporated (NASDAQ:), a leading global manufacturer and supplier of high-quality application-specific standard products within...
The airline on Thursday confirmed that it was pursuing legal claims against CrowdStrike and Microsoft Corp. to recover damages.
The commission said it "will assess Apple's eventual changes to the compliance measures, also taking into account any feedback from the market, notably developers".
The beverage company has been in a long-drawn dispute with tax authorities in the U.S. over a $16 billion charge that it could possibly owe.